Man‐Yu Xu

403 total citations
14 papers, 314 citations indexed

About

Man‐Yu Xu is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Man‐Yu Xu has authored 14 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Man‐Yu Xu's work include Alzheimer's disease research and treatments (7 papers), Receptor Mechanisms and Signaling (3 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). Man‐Yu Xu is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Receptor Mechanisms and Signaling (3 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). Man‐Yu Xu collaborates with scholars based in China, Russia and Australia. Man‐Yu Xu's co-authors include Xinquan Wang, Yan‐Jiang Wang, Xian‐Le Bu, Xiaopeng Zhu, Ying‐Ying Shen, Xi Liu, Zhiqiang Xu, Jun Wang, Cheng‐Rong Tan and Gui‐Hua Zeng and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Acta Neuropathologica.

In The Last Decade

Man‐Yu Xu

13 papers receiving 314 citations

Peers

Man‐Yu Xu
Kristin A. Kwakwa United States
Li Yuan United States
Garry Whitehead United Kingdom
Man‐Yu Xu
Citations per year, relative to Man‐Yu Xu Man‐Yu Xu (= 1×) peers Ilaria Raimondi

Countries citing papers authored by Man‐Yu Xu

Since Specialization
Citations

This map shows the geographic impact of Man‐Yu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man‐Yu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man‐Yu Xu more than expected).

Fields of papers citing papers by Man‐Yu Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man‐Yu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man‐Yu Xu. The network helps show where Man‐Yu Xu may publish in the future.

Co-authorship network of co-authors of Man‐Yu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Man‐Yu Xu. A scholar is included among the top collaborators of Man‐Yu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man‐Yu Xu. Man‐Yu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Xu, Man‐Yu, Xu Yi, Qinghua Wang, et al.. (2025). Trajectory of changes in myelin basic protein levels in cerebrospinal fluid during ageing and its association with biomarkers of Alzheimer’s disease. Translational Psychiatry. 15(1). 149–149. 2 indexed citations
2.
Cheng, Yuan, Chen-Yang He, Ding‐Yuan Tian, et al.. (2023). Physiological β-amyloid clearance by the liver and its therapeutic potential for Alzheimer’s disease. Acta Neuropathologica. 145(6). 717–731. 62 indexed citations
3.
Yu, Zhongyuan, Man‐Yu Xu, Zhihao Liu, et al.. (2022). Effects of Chemotherapy on Neuroinflammation, Neuronal Damage, Neurogenesis, and Behavioral Performance in Bone Marrow Transplantation Recipient Mice. Neurotoxicity Research. 40(2). 585–595.
4.
Cheng, Yuan, Chen-Yang He, Man‐Yu Xu, et al.. (2022). Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer’s disease. Translational Psychiatry. 12(1). 194–194. 8 indexed citations
5.
Cheng, Yuan, Chen-Yang He, Man‐Yu Xu, et al.. (2022). The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer’s Disease. Journal of Alzheimer s Disease. 88(1). 375–383. 8 indexed citations
6.
Xu, Yi, Yujia Yang, Man‐Yu Xu, et al.. (2021). Serum mBDNF and ProBDNF Expression Levels as Diagnosis Clue for Early Stage Parkinson's Disease. Frontiers in Neurology. 12. 680765–680765. 17 indexed citations
7.
Xu, Man‐Yu, Zhiqiang Xu, & Yan‐Jiang Wang. (2021). White Matter “Matters” in Alzheimer’s Disease. Neuroscience Bulletin. 38(3). 323–326. 6 indexed citations
8.
Chen, Sihan, Chen-Yang He, Ying‐Ying Shen, et al.. (2021). Polysaccharide Krestin Prevents Alzheimer’s Disease-type Pathology and Cognitive Deficits by Enhancing Monocyte Amyloid-β Processing. Neuroscience Bulletin. 38(3). 290–302. 18 indexed citations
9.
Zhu, Xiaopeng, Si Pan, Man‐Yu Xu, et al.. (2020). High Selectivity of an α-Conotoxin LvIA Analogue for α3β2 Nicotinic Acetylcholine Receptors Is Mediated by β2 Functionally Important Residues. Journal of Medicinal Chemistry. 63(22). 13656–13668. 25 indexed citations
10.
Shen, Lin‐Lin, Weiwei Li, Yali Xu, et al.. (2019). Neurotrophin receptor p75 mediates amyloid β-induced tau pathology. Neurobiology of Disease. 132. 104567–104567. 44 indexed citations
11.
Sun, Hao‐Lun, Bin‐Lu Sun, Dong‐Wan Chen, et al.. (2019). Plasma α‐synuclein levels are increased in patients with obstructive sleep apnea syndrome. Annals of Clinical and Translational Neurology. 6(4). 788–794. 25 indexed citations
13.
Zhao, Hongyu, Hui Wei, Xi Liu, et al.. (2016). Structural Insights on PHA Binding Protein PhaP from Aeromonas hydrophila. Scientific Reports. 6(1). 39424–39424. 34 indexed citations
14.
Lin, Bo, Man‐Yu Xu, Xiaopeng Zhu, et al.. (2016). From crystal structure of α-conotoxin GIC in complex with Ac-AChBP to molecular determinants of its high selectivity for α3β2 nAChR. Scientific Reports. 6(1). 22349–22349. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026